AbbVie Will Use Allergan Revenue To Fund Combined Firm's Large R&D Pipeline

 
• By Mandy Jackson
R&D
Botox and other Allergan products will fund AbbVie's diversification. • Source: Shutterstock

More from Deals

More from Business